🇺🇸 FDA
Pipeline program

Topical Minocycline Foam FXFM244

FX2010-03

Phase 2 small_molecule completed

Quick answer

Topical Minocycline Foam FXFM244 for Acne Vulgaris is a Phase 2 program (small_molecule) at VYNE Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
VYNE Therapeutics
Indication
Acne Vulgaris
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials